Trial intelligence / Profile preview

Fanapt in Schizophrenia and Schizoaffective Disorder

NCT01929889Phase 4Terminated

Sponsor
Northwestern University
Start
Apr 2012
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iloperidone in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Apr 2012; status: terminated.

02

Drugs

iloperidone
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT01929889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01929889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call